Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Akbar Molazahi"'
Autor:
Sine Buhl, Casper Steenholdt, Jørn Brynskov, Katrine Risager Christensen, Maria Dorn-Rasmussen, Ole Østergaard Thomsen, Klaus Bendtzen, Tobias Wirenfeldt Klausen, Jens Frederik Dahlerup, Niels Thorsgaard, Jørgen Jahnsen, Akbar Molazahi, Natalia Pedersen, Jens Kjeldsen, Sven Almer, Eva Efsen Dahl, Ida Vind, Annett Gerhardt Cannon, Jan Marsal, Taina Sipponen, Jørgen Steen Agnholt, Hendrika Adriana Linda Kievit, Synnøve Louise Aure, Lars Martinsen, Svetlana Meisner, Jane Møller Hansen, Mark Andrew Ainsworth
Publikováno v:
NEJM Evidence. 1
Autor:
Mohamed Attauabi, Klaus Theede, Lone Heimann Larsen, Tine Jess, Michael Dam Jensen, August Pilegaard Prahm, Asser Mathiassen Oppfeldt, Malte Rosager Hansen, Jakob Benedict Seidelin, Natalia Pedersen, Sule Eraslan, Marianne Kiszka-Kanowitz, Johan Burisch, Marianne Kajbæk Verner-Andersen, Anja Poulsen, Anders Berg Lødrup, Jens Frederik Dahlerup, Henning Glerup, Akbar Molazahi, Anders Neumann, Kent V. Haderslev
Publikováno v:
Attauabi, M, Dahlerup, J F, Poulsen, A, Hansen, M R, Verner-Andersen, M K, Eraslan, S, Prahm, A P, Pedersen, N, Larsen, L, Jess, T, Neumann, A, Haderslev, K V, Molazahi, A, Lødrup, A B, Glerup, H, Oppfeldt, A M, Jensen, M D, Theede, K, Kiszka-Kanowitz, M, Seidelin, J B, Burisch, J & the Danish COVID-IBD Study Group 2022, ' Outcomes and long-term effects of COVID-19 in patients with inflammatory bowel diseases-a Danish prospective population-based cohort study with individual-level data ', Journal of Crohn's & colitis, vol. 16, no. 5, jjab192, pp. 757–767 . https://doi.org/10.1093/ecco-jcc/jjab192
Attauabi, M, Dahlerup, J F, Poulsen, A, Hansen, M R, Vester-Andersen, M K, Eraslan, S, Prahm, A P, Pedersen, N, Larsen, L, Jess, T, Neumann, A, Haderslev, K V, Molazahi, A, Lødrup, A B, Glerup, H, Oppfeldt, A M, Jensen, M D, Theede, K, Kiszka-Kanowitz, M, Seidelin, J B, Burisch, J & Danish COVID-IBD Study Group 2022, ' Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases-A Danish Prospective Population-Based Cohort Study with Individual-Level Data ', Journal of Crohn's & colitis, vol. 16, no. 5, pp. 757-767 . https://doi.org/10.1093/ecco-jcc/jjab192
Journal of Crohn's & Colitis
Attauabi, M, Dahlerup, J F, Poulsen, A, Hansen, M R, Vester-Andersen, M K, Eraslan, S, Prahm, A P, Pedersen, N, Larsen, L, Jess, T, Neumann, A, Haderslev, K V, Molazahi, A, Lødrup, A B, Glerup, H, Oppfeldt, A M, Jensen, M D, Theede, K, Kiszka-Kanowitz, M, Seidelin, J B, Burisch, J & Danish COVID-IBD Study Group 2022, ' Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases-A Danish Prospective Population-Based Cohort Study with Individual-Level Data ', Journal of Crohn's & colitis, vol. 16, no. 5, pp. 757-767 . https://doi.org/10.1093/ecco-jcc/jjab192
Journal of Crohn's & Colitis
Background and Aims The health consequences of coronavirus disease 2019 [COVID-19] among patients with ulcerative colitis [UC] and Crohn’s disease [CD] remain largely unknown. We aimed to investigate the outcomes and long-term effects of COVID-19 i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65a5890016b3b0e98e6ebf85d3a910be
https://vbn.aau.dk/da/publications/085933f1-8b1a-4a20-bb1e-97f3a3710eb6
https://vbn.aau.dk/da/publications/085933f1-8b1a-4a20-bb1e-97f3a3710eb6
Autor:
Mohamed Attauabi, Jens Frederik Dahlerup, Anja Poulsen, Malte Rosager Hansen, Marianne Kajbæk Vester-Andersen, August Pilegaard Prahm, Natalia Pedersen, Lone Larsen, Tine Jess, Anders Neumann, Kent V Haderslev, Akbar Molazahi, Anders Berg Lødrup, Henning Glerup, Asser Mathiassen Oppfeldt, Michael Dam Jensen, Klaus Theede, Marianne Kiszka-Kanowitz, Jakob Benedict Seidelin, Johan Burisch
Publikováno v:
Attauabi, M, Dahlerup, J F, Poulsen, A, Hansen, M R, Vester-Andersen, M K, Prahm, A P, Pedersen, N, Larsen, L, Jess, T, Neumann, A, Haderslev, K V, Molazahi, A, Lødrup, A B, Glerup, H, Oppfeldt, A M, Jensen, M D, Theede, K, Kiszka-Kanowitz, M, Seidelin, J B & Burisch, J 2022, ' Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study ', Inflammatory Bowel Diseases, vol. 28, no. 10, pp. 1618-1622 . https://doi.org/10.1093/ibd/izac052
Attauabi, M, Dahlerup, J F, Poulsen, A, Hansen, M R, Vester-Andersen, M K, Prahm, A P, Pedersen, N, Larsen, L, Jess, T, Neumann, A, Haderslev, K V, Molazahi, A, Lødrup, A B, Glerup, H, Oppfeldt, A M, Jensen, M D, Theede, K, Kiszka-Kanowitz, M, Seidelin, J B, Burisch, J & the Danish COVID-IBD Study Group 2022, ' Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study ', Inflammatory Bowel Diseases, vol. 28, no. 10, izac052, pp. 1618-1622 . https://doi.org/10.1093/ibd/izac052
Attauabi, M, Dahlerup, J F, Poulsen, A, Hansen, M R, Vester-Andersen, M K, Prahm, A P, Pedersen, N, Larsen, L, Jess, T, Neumann, A, Haderslev, K V, Molazahi, A, Lødrup, A B, Glerup, H, Oppfeldt, A M, Jensen, M D, Theede, K, Kiszka-Kanowitz, M, Seidelin, J B, Burisch, J & the Danish COVID-IBD Study Group 2022, ' Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study ', Inflammatory Bowel Diseases, vol. 28, no. 10, izac052, pp. 1618-1622 . https://doi.org/10.1093/ibd/izac052
Lay Summary This brief report investigated the impact of clinical, biochemical, and endoscopic activity of IBD on the severity and long-term outcomes of COVID-19 in a prospective population-based cohort. The study did not identify any association bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8b9b8d8c9c47eb71ec7e44e4a1d2e34
https://curis.ku.dk/portal/da/publications/association-between-the-clinical-biochemical-and-endoscopic-activity-of-inflammatory-bowel-diseases-and-severity-and-longterm-outcomes-of-coronavirus-disease-2019--a-populationbased-study(0296d0a3-f598-4abb-9333-0197831886ef).html
https://curis.ku.dk/portal/da/publications/association-between-the-clinical-biochemical-and-endoscopic-activity-of-inflammatory-bowel-diseases-and-severity-and-longterm-outcomes-of-coronavirus-disease-2019--a-populationbased-study(0296d0a3-f598-4abb-9333-0197831886ef).html
Autor:
Jakob Benedict Seidelin, Natalia Pedersen, Kent V. Haderslev, Marianne Kajbæk Verner-Andersen, Klaus Theede, Johan Burisch, Anders Berg Lødrup, Abdel Wase, Tine Jess, Mohamed Attauabi, Lone Larsen, Anders Neumann, Malte Rosager Hansen, Anja Poulsen, Akbar Molazahi
Publikováno v:
Attauabi, M, Poulsen, A, Theede, K, Pedersen, N, Larsen, L, Jess, T, Rosager Hansen, M, Kajbæk Verner-Andersen, M, V Haderslev, K, Berg Lødrup, A, Molazahi, A, Neumann, A, Wase, A, Seidelin, J B & Burisch, J 2021, ' Prevalence and outcomes of COVID-19 among patients with inflammatory bowel disease-A Danish prospective population-based cohort study ', Journal of Crohn's & colitis, vol. 15, no. 4, pp. 540–550 . https://doi.org/10.1093/ecco-jcc/jjaa205
Attauabi, M, Poulsen, A, Theede, K, Pedersen, N, Larsen, L, Jess, T, Rosager Hansen, M, Kajbæk Verner-Andersen, M, V Haderslev, K, Berg Lødrup, A, Molazahi, A, Neumann, A, Wase, A, Seidelin, J B, Burisch, J & the Danish COVID-IBD Study Group 2021, ' Prevalence and outcomes of COVID-19 among patients with inflammatory bowel disease-A Danish prospective population-based cohort study ', Journal of Crohn's & colitis, vol. 15, no. 4, pp. 540–550 . https://doi.org/10.1093/ecco-jcc/jjaa205
Journal of Crohns and Colitis
Journal of Crohn's & Colitis
Attauabi, M, Poulsen, A, Theede, K, Pedersen, N, Larsen, L, Jess, T, Rosager Hansen, M, Kajbæk Verner-Andersen, M, V Haderslev, K, Berg Lødrup, A, Molazahi, A, Neumann, A, Wase, A, Seidelin, J B, Burisch, J & the Danish COVID-IBD Study Group 2021, ' Prevalence and outcomes of COVID-19 among patients with inflammatory bowel disease-A Danish prospective population-based cohort study ', Journal of Crohn's & colitis, vol. 15, no. 4, pp. 540–550 . https://doi.org/10.1093/ecco-jcc/jjaa205
Journal of Crohns and Colitis
Journal of Crohn's & Colitis
Background and Aims As no population-based study has investigated the susceptibility and disease course of COVID-19 among patients with inflammatory bowel diseases [IBD], we aimed to investigate this topic in a population-based setting. Methods Two c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97f1a3c958c457c1d445e276decc6110
https://pure.au.dk/portal/da/publications/prevalence-and-outcomes-of-covid19-among-patients-with-inflammatory-bowel-disease--a-danish-prospective-populationbased-cohort-study(bdf633fc-fada-4f5e-a9ee-a08d870feba6).html
https://pure.au.dk/portal/da/publications/prevalence-and-outcomes-of-covid19-among-patients-with-inflammatory-bowel-disease--a-danish-prospective-populationbased-cohort-study(bdf633fc-fada-4f5e-a9ee-a08d870feba6).html
Autor:
Niels C Pedersen, Mohamed Attauabi, Jens Kjeldsen, Jakob Benedict Seidelin, Claus Aalykke, K B Pedersen, Curt Lind, Janne Fassov, C Hoglund, Flemming Bendtsen, Wojciech Cebula, P Munkholm, H Albaek Jacobsen, K Haderselv, B Johan, Akbar Molazahi, M Dam Jensen, H Bansholm Hansen, Signe Wildt, Anders Neumann, Torben Knudsen, A M Popa
Publikováno v:
Journal of Crohn's and Colitis. 15:S369-S370
Background Data regarding the efficacy and safety of vedolizumab as the first line of biologic therapy for elderly patients with ulcerative colitis (UC) and Crohn’s disease (CD) or patients with contraindications against anti-tumor necrosis factor
Autor:
M Kajbaek Verner-Andersen, Tine Jess, Anders Neumann, Jens Frederik Dahlerup, A Pilegaard Prahm, L. Larsen, Torben Nathan, K Haderselv, Simone Jensen, Marianne Kiszka-Kanowitz, Anne Katrine Hartmann Poulsen, C Lodberg Hvas, A Berg Lødrup, A Wase, M Rosager Hansen, M Dam Jensen, K Theede, Akbar Molazahi, Henning Glerup, J Benedict Seidelin, Niels C Pedersen, Mohamed Attauabi, A Mathiassen Oppfeldt, Johan Burisch
Publikováno v:
Journal of Crohn's & Colitis
Background Population-based data regarding outcomes of coronavirus disease 2019 (COVID-19) among patients with ulcerative colitis (UC) and Crohn’s disease (CD) are limited. Studies on the association of COVID-19 outcomes and immunomodulating therap
Autor:
Svetlana Meisner, Jørgen Jahnsen, Ida Vind, Klaus Bendtzen, Maria Dorn-Rasmussen, Lars Martinsen, Niels Thorsgaard, Sven Almer, Hendrika Adriana Linda Kievit, Jane Moeller, Sine Buhl, Taina Sipponen, Akbar Molazahi, Eva E. Dahl, Jens Kjeldsen, Mark A. Ainsworth, Katrine R. Christensen, Casper Steenholdt, Jens Frederik Dahlerup, Jan Marsal, Synn⊘ve L. Aure, J⊘rn Brynskov, Ole Østergaard Thomsen, Natalia Pedersen, Tobias Wirenfeldt Klausen, J⊘rgen Steen Agnholt, Annett G. Cannon
Publikováno v:
Gastroenterology. 160:S-151
Background It remains unknown whether infliximab (IFX) successfully can be discontinued once Crohn's disease (CD) patients have attained sustained, complete clinical, biochemical, and endoscopic remission. No randomized, placebo (PBO) controlled tria
Autor:
Jørn Brynskov, Mark A. Ainsworth, Ole Østergaard Thomsen, Akbar Molazahi, Jakob Benedict Seidelin, Casper Steenholdt
Publikováno v:
Scandinavian Journal of Gastroenterology. 47:518-527
To investigate duration of remission, including risk factors for relapse and response to retreatment with infliximab (IFX), in patients with Crohn's disease (CD) and ulcerative colitis (UC) who had discontinued IFX while in clinical remission.Observa
Autor:
Akbar Molazahi, Jørn Brynskov, Mark A. Ainsworth, Jakob Benedict Seidelin, Casper Steenholdt, Ole Østergaard Thomsen
Publikováno v:
Journal of Crohn's and Colitis. 6:S111-S112
Autor:
Jakob Benedict Seidelin, Akbar Molazahi, Mark A. Ainsworth, Ole Østergaard Thomsen, Jørn Brynskov, Casper Steenholdt
Publikováno v:
Gastroenterology. 142:S-204